8-K Announcements
6Material company update
Apr 20, 2026·SEC
Material company update
Dec 23, 2025·SEC
Material company update
Nov 7, 2025·SEC
OneMedNet Corporation(ONMD)Earnings, Financials & Key Ratios
ONMD•NASDAQ
$0.96
$32M mkt cap·Price updated May 6, 2026
AboutOneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. The company is based in Eden Prairie, Minnesota.Show more
- Revenue$1M+111.4%
- EBITDA-$10M-0.6%
- Net Income-$3M+72.3%
- EPS (Diluted)-0.06+83.3%
- Gross Margin-37.01%+15.3%
- EBITDA Margin-706.55%+52.4%
- Operating Margin-711.33%+52.4%
- Net Margin-206.11%+86.9%
- Interest Coverage-40.79+39.9%
ONMD Key Insights
OneMedNet Corporation (ONMD) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓High quality earnings: Operating CF exceeds net income
- ✓Strong 5Y sales CAGR of 10.5%
✗Weaknesses
- ✗Negative free cash flow
- ✗Shares diluted 58.7% in last year
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
ONMD Price & Volume
OneMedNet Corporation (ONMD) stock price & volume — 10-year historical chart
Loading chart...
ONMD Growth Metrics
OneMedNet Corporation (ONMD) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years10.52%
3 Years5.63%
TTM111.35%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM72.35%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM84.91%
Return on Capital
10 Years-
5 Years-
3 Years-
Last Year-
ONMD Peer Comparison
OneMedNet Corporation (ONMD) competitors in Life Sciences and Precision Medicine Software — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 NVCR | 1.88B | 16.50 | -13.52 | 8.28% | -25.66% | -50.82% | 0.85 | |
 HCAT | 111.47M | 1.57 | -0.62 | 1.48% | -57.2% | -54.67% | 0.08 | |
 DOCS | 5.17B | 25.69 | 23.14 | 19.98% | 37.54% | 24.45% | 0.01 | |
 PHVS | 1.96B | 30.11 | -10.35 | -53.18% | 0.00 | |||
 INVA | 1.91B | 22.52 | 6.82 | 18.52% | 118.91% | 46.47% | 0.23 | |
 MTEX | 9.28M | 4.88 | 3.70 | -10.68% | -1.5% | -23.83% | 0.78 | |
 VEEV | 27.2B | 167.29 | 30.75 | 16.34% | 28.44% | 13.41% | 0.01 | |
 ISRG | 160.44B | 451.73 | 57.40 | 20.51% | 28.15% | 16.89% | 0.02 |
Compare ONMD vs Peers
OneMedNet Corporation (ONMD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
ONMD Income Statement
OneMedNet Corporation (ONMD) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|
| Sales/Revenue | 824.03K | 1.09M | 1.15M | 1.02M | 643K | 1.36M |
| Revenue Growth % | - | 32.49% | 5.61% | -11.45% | -37.02% | 111.35% |
| Cost of Goods Sold | 611.66K | 1.21M | 1.51M | 1.15M | 924K | 1.86M |
| COGS % of Revenue | 74.23% | 110.39% | 131.22% | 112.63% | 143.7% | 137.01% |
| Gross Profit | 212.37K▲ 0% | -113.41K▼ 153.4% | -360K▼ 217.4% | -129K▲ 64.2% | -281K▼ 117.8% | -503K▼ 79.0% |
| Gross Margin % | 25.77% | -10.39% | -31.22% | -12.63% | -43.7% | -37.01% |
| Gross Profit Growth % | - | -153.4% | -217.44% | 64.17% | -117.83% | -79% |
| Operating Expenses | 3.14M | 2.6M | 7.36M | 6.72M | 9.32M | 9.16M |
| OpEx % of Revenue | 381.6% | 237.88% | 637.9% | 658.57% | 1450.08% | 674.32% |
| Selling, General & Admin | 2.38M | 1.8M | 13.84M | 4.66M | 7.86M | 7.65M |
| SG&A % of Revenue | 289.14% | 165.05% | 1200.09% | 456.32% | 1221.93% | 562.84% |
| Research & Development | 307.27K | 642.76K | 1.59M | 2.06M | 1.47M | 1.51M |
| R&D % of Revenue | 37.29% | 58.87% | 137.99% | 202.25% | 228.15% | 111.48% |
| Other Operating Expenses | 454.61K | 152.46K | -8.07M | 0 | 0 | 0 |
| Operating Income | -2.93M▲ 0% | -2.71M▲ 7.6% | -7.71M▼ 184.6% | -6.85M▲ 11.2% | -9.61M▼ 40.2% | -9.67M▼ 0.6% |
| Operating Margin % | -355.82% | -248.27% | -669.12% | -671.2% | -1493.78% | -711.33% |
| Operating Income Growth % | - | 7.56% | -184.63% | 11.17% | -40.16% | -0.65% |
| EBITDA | -2.92M | -2.7M | -7.69M | -6.83M | -9.55M | -9.6M |
| EBITDA Margin % | -354.14% | -246.95% | -666.96% | -668.46% | -1484.91% | -706.55% |
| EBITDA Growth % | - | 7.61% | -185.23% | 11.25% | -39.9% | -0.57% |
| D&A (Non-Cash Add-back) | 13.92K | 14.47K | 25K | 28K | 57K | 65K |
| EBIT | -2.93M | -2.75M | -30.43M | -33.75M | -9.98M | -2.73M |
| Net Interest Income | 193.55K | -195.38K | -403.31K | -11K | -147K | -67K |
| Interest Income | 193.55K | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 195.38K | 403.31K | 11K | 147K | 67K |
| Other Income/Expense | 110.55K | -230.29K | -22.72M | -26.91M | -522K | 6.87M |
| Pretax Income | -2.82M▲ 0% | -2.94M▼ 4.2% | -30.43M▼ 934.9% | -33.76M▼ 10.9% | -10.13M▲ 70.0% | -2.8M▲ 72.4% |
| Pretax Margin % | -342.41% | -269.37% | -2639.55% | -3306.76% | -1574.96% | -206.03% |
| Income Tax | 0 | 0 | 17K | 18K | 2K | 1K |
| Effective Tax Rate % | 0% | 0% | -0.06% | -0.05% | -0.02% | -0.04% |
| Net Income | -2.82M▲ 0% | -2.94M▼ 4.2% | -30.45M▼ 935.4% | -33.78M▼ 10.9% | -10.13M▲ 70.0% | -2.8M▲ 72.3% |
| Net Margin % | -342.41% | -269.37% | -2641.02% | -3308.52% | -1575.27% | -206.11% |
| Net Income Growth % | - | -4.23% | -935.44% | -10.93% | 70.01% | 72.35% |
| Net Income (Continuing) | -2.82M | -2.94M | -30.45M | -33.78M | -10.13M | -2.8M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.19▲ 0% | -0.20▼ 5.3% | -2.51▼ 1155.0% | -4.77▼ 90.0% | -0.36▲ 92.5% | -0.06▲ 83.3% |
| EPS Growth % | - | -5.26% | -1155% | -90.04% | 92.45% | 83.33% |
| EPS (Basic) | -0.19 | -0.20 | -2.51 | -4.77 | -0.36 | -0.06 |
| Diluted Shares Outstanding | 14.96M | 14.96M | 12.13M | 7.08M | 28.08M | 44.55M |
| Basic Shares Outstanding | 14.96M | 14.96M | 12.13M | 7.08M | 28.08M | 44.55M |
| Dividend Payout Ratio | - | - | - | - | - | - |
ONMD Balance Sheet
OneMedNet Corporation (ONMD) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|
| Total Current Assets | 293.62K | 833.29K | 391K | 364.19K | 3.62M | 2.1M |
| Cash & Short-Term Investments | 79.18K | 699.32K | 271K | 47.01K | 3.02M | 1.09M |
| Cash Only | 79.18K | 699.32K | 271K | 47.01K | 172K | 585K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 2.85M | 506K |
| Accounts Receivable | 195.37K | 91.74K | 19K | 151.64K | 213K | 495K |
| Days Sales Outstanding | 86.54 | 30.67 | 6.01 | 54.21 | 120.91 | 132.95 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - |
| Other Current Assets | 19.07K | 42.23K | 101K | 165.54K | 385K | 509K |
| Total Non-Current Assets | 34.3K | 49.77K | 898K | 98.87K | 108K | 56K |
| Property, Plant & Equipment | 34.3K | 49.77K | 83K | 98.87K | 108K | 56K |
| Fixed Asset Turnover | 24.03x | 21.94x | 13.89x | 10.33x | 5.95x | 24.27x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 815K | 0 | 0 | 0 |
| Total Assets | 327.91K▲ 0% | 883.06K▲ 169.3% | 1.29M▲ 46.0% | 463.06K▼ 64.1% | 3.73M▲ 704.9% | 2.15M▼ 42.3% |
| Asset Turnover | 2.51x | 1.24x | 0.89x | 2.20x | 0.17x | 0.63x |
| Asset Growth % | - | 169.3% | 45.97% | -64.08% | 704.87% | -42.29% |
| Total Current Liabilities | 1.55M | 4.75M | 26.1M | 12.83M | 19.23M | 4.83M |
| Accounts Payable | 0 | 0 | 1.18M | 4.18M | 6.37M | 0 |
| Days Payables Outstanding | - | - | 283.94 | 1.33K | 2.52K | - |
| Short-Term Debt | 1.05M | 3.35M | 24.74M | 4.64M | 8.76M | 350K |
| Deferred Revenue (Current) | 106.37K | 642.35K | 184K | 254K | 561K | 389K |
| Other Current Liabilities | 391.12K | 758.82K | 0 | 0 | 283K | 3.79M |
| Current Ratio | 0.19x | 0.18x | 0.01x | 0.03x | 0.19x | 0.43x |
| Quick Ratio | 0.19x | 0.18x | 0.01x | 0.03x | 0.19x | 0.43x |
| Cash Conversion Cycle | - | - | - | - | - | - |
| Total Non-Current Liabilities | 1.64M | 1.83M | 1.54M | 489.61K | 449K | 291K |
| Long-Term Debt | 1.55M | 1.55M | 1.5M | 465.02K | 0 | 220K |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 93.19K | 287.61K | 44K | 24.58K | 449K | 71K |
| Total Liabilities | 3.19M | 6.59M | 27.65M | 13.32M | 19.68M | 5.12M |
| Total Debt | 2.6M | 4.9M | 26.24M | 5.1M | 8.76M | 570K |
| Net Debt | 2.52M | 4.2M | 25.97M | 5.05M | 8.59M | -15K |
| Debt / Equity | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - |
| Interest Coverage | - | -14.05x | -75.46x | -3068.27x | -67.89x | -40.79x |
| Total Equity | -2.86M▲ 0% | -5.7M▼ 99.4% | -26.36M▼ 362.2% | -12.86M▲ 51.2% | -15.95M▼ 24.0% | -2.96M▲ 81.4% |
| Equity Growth % | - | -99.42% | -362.23% | 51.21% | -24.03% | 81.41% |
| Book Value per Share | -0.19 | -0.38 | -2.17 | -1.82 | -0.57 | -0.07 |
| Total Shareholders' Equity | -2.86M | -5.7M | -26.36M | -12.86M | -15.95M | -2.96M |
| Common Stock | 383 | 434 | 0 | 2.36K | 2K | 2K |
| Retained Earnings | -22.37M | -25.31M | -57.66M | -55.08M | -101.57M | -104.37M |
| Treasury Stock | 0 | 0 | 0 | 0 | -529K | -529K |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
ONMD Cash Flow Statement
OneMedNet Corporation (ONMD) cash flow — operating, investing & free cash flow history
| Line item | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|
| Cash from Operations | -2.13M | -1.84M | -4.7M | -4.79M | -6.98M | -7.5M |
| Operating CF Margin % | -257.88% | -168.94% | -407.89% | -469.25% | -1086% | -552.1% |
| Operating CF Growth % | - | 13.21% | -154.99% | -1.87% | -45.75% | -7.45% |
| Net Income | -2.82M | -2.94M | -30.45M | -33.78M | -10.13M | -2.8M |
| Depreciation & Amortization | 13.92K | 14.47K | 25K | 28K | 57K | 65K |
| Stock-Based Compensation | 606.51K | 97.87K | 1.86M | 1.48M | 628K | 2.03M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -234.5K | 0 | 23.89M | 26.88M | 956K | -6.91M |
| Working Capital Changes | 310.59K | 984.13K | -29K | 611K | 1.5M | 106K |
| Change in Receivables | -91.89K | 81.09K | 73K | -133K | -61K | -282K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | 0 | 1.93M | 717K | 1.49M | 0 |
| Cash from Investing | 0 | -29.94K | -58K | -44K | -1.98M | 2.31M |
| Capital Expenditures | 0 | -29.94K | -58K | -44K | -51K | -13K |
| CapEx % of Revenue | - | 2.74% | 5.03% | 4.31% | 7.93% | 0.96% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 1.33M | 2.49M | 4.33M | 4.61M | 9.09M | 5.61M |
| Debt Issued (Net) | 1.33M | 2.49M | 5.14M | 6.13M | 3.12M | 1.87M |
| Equity Issued (Net) | 0 | 0 | -85.72M | 16K | 6.07M | 2.56M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | -88.55M | 0 | -200K | 0 |
| Other Financing | 0 | 0 | 84.92M | -1.53M | -100K | 1.18M |
| Net Change in Cash | -816.05K▲ 0% | 620.14K▲ 176.0% | -428K▼ 169.0% | -224K▲ 47.7% | 125K▲ 155.8% | 413K▲ 230.4% |
| Free Cash Flow | -2.13M▲ 0% | -1.87M▲ 11.8% | -4.76M▼ 154.0% | -4.83M▼ 1.6% | -7.03M▼ 45.5% | -7.52M▼ 6.9% |
| FCF Margin % | -257.88% | -171.68% | -412.92% | -473.56% | -1093.93% | -553.05% |
| FCF Growth % | - | 11.8% | -154.01% | -1.55% | -45.48% | -6.85% |
| FCF per Share | -0.14 | -0.13 | -0.39 | -0.68 | -0.25 | -0.17 |
| FCF Conversion (FCF/Net Income) | 0.75x | 0.63x | 0.15x | 0.14x | 0.69x | 2.68x |
| Interest Paid | 0 | 0 | 0 | 0 | 26K | 23K |
| Taxes Paid | 0 | 0 | 0 | 0 | 18K | 1K |
ONMD Key Ratios
OneMedNet Corporation (ONMD) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Gross Margin | 25.77% | -10.39% | -31.22% | -12.63% | -43.7% | -37.01% |
| Net Margin | -342.41% | -269.37% | -2641.02% | -3308.52% | -1575.27% | -206.11% |
| Interest Coverage | - | -14.05x | -75.46x | -3068.27x | -67.89x | -40.79x |
| FCF Conversion | 0.75x | 0.63x | 0.15x | 0.14x | 0.69x | 2.68x |
| Revenue Growth | - | 32.49% | 5.61% | -11.45% | -37.02% | 111.35% |
ONMD SEC Filings & Documents
OneMedNet Corporation (ONMD) SEC filings — annual & quarterly reports (10-K, 10-Q)
ONMD Frequently Asked Questions
OneMedNet Corporation (ONMD) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
OneMedNet Corporation (ONMD) reported $1.4M in revenue for fiscal year 2025. This represents a 65% increase from $0.8M in 2020.
OneMedNet Corporation (ONMD) grew revenue by 111.4% over the past year. This is strong growth.
OneMedNet Corporation (ONMD) reported a net loss of $2.8M for fiscal year 2025.
Dividend & Returns
OneMedNet Corporation (ONMD) had negative free cash flow of $7.5M in fiscal year 2025, likely due to heavy capital investments.
Explore More ONMD
OneMedNet Corporation (ONMD) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates